Dementia can affect a person's sexual behaviour, sometimes meaning they are less or more interested in sex. Partners of a person with dementia may also feel differently about sex and intimacy. Find ...

Working at Alzheimer's Society, you'll make a real difference to people's lives. Add to that our attractive rewards and benefits package and you’ll understand why there has never been a better time to ...

From the June/July 2016 issue of our magazine, Heather Stephen learns about the Herbert Protocol, which is speeding up searches for vulnerable people, including those with dementia.

The most important part of sex and intimacy is consent. A diagnosis of dementia does not mean that someone automatically lacks the ability to consent to sex and intimacy. However, they may have the ...

Patient and public involvement (PPI) is the philosophy that research is carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them.

Organising and going on holiday without extra support can be difficult for people living with a disability like dementia. But taking time away from home can be just as important to them. There are ...

Physical health and your memory Just because you have dementia doesn’t mean you should feel unwell. Looking after your physical health can help with your memory. Try to eat balanced meals and drink ...

If a person with dementia is grieving, it’s important to support them. Read our tips on helping them grieve, as well as advice if they're asking for the person who has died.

Turning Up the Volume is the largest-ever survey with people with dementia to hear their views and experiences of what daily life is like.

Val Horncastle, who had Alzheimer’s disease, came up with the idea for the ‘Memory Calendar’ with her husband Keith. We hear how a calendar designed to help one person is benefiting many others.

There are ways to make it easier for people with dementia to manage their money. This includes staying protected from financial scams.

Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, has called breakthrough Alzheimer's drug donanemab, 'a turning point', as the full trial results were revealed.